DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC.Fabrice André, Komal Jhaveri, Sherene Loi et al.|Journal of Clinical Oncology|2024Cited by 32